Targeting PYK2 with Heterobifunctional T6BP Helps Mitigate MASLD and MASH-HCC Progression

Minxuan Xu,Junjie Zhao,Liancai Zhu,Chenxu Ge,Yan Sun, Ranran Wang, Yuanyuan Li,Xianling Dai,Qin Kuang,Linfeng Hu,Jing Luo,Gang Kuang,Yanrong Ren,Bochu Wang, Jun Tan,Shengbin Shi

JOURNAL OF HEPATOLOGY（2025）

Cited 1|Views11

Key words

TRAF6-binding protein (T6BP),Protein tyrosine kinase 2 beta (PYK2),Metabolic dysfunction-associated steatotic liver disease (MASLD),Metabolic dysfunction-associated steatohepatitis (MASH),MASLD-related HCC (MASH-HCC)

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined